Back to search

Boston University

Molecular subtypes of airway field gene expression alterations are associated with lung cancer phenotypes

Abstract

dc:description.abstract

Lung cancer is the leading cause of cancer mortality. This is primarily due to a lack of interventions to prevent lung premalignant lesions from progressing to invasive cancer, and due to the challenges of early cancer detection when disease is at more treatable stages. Despite past research conducting multi-omic profiling of lung premalignant lesions and lung tumors, the earliest molecular changes associated with lung carcinogenesis are not fully elucidated. To improve lung cancer detection using relatively non-invasive samples, we sought to understand the relationship between gene signatures associated with lung cancer and lung squamous premalignant severity in airway biopsies and bronchial brushings. To improve lung cancer prevention, we studied the molecular alterations associated with lung adenocarcinoma premalignant lesions and assessed their similarity to aggressive tumors. First, we analyzed bulk mRNA sequencing of samples collected from bronchial brushings and endobronchial biopsies from patients with a history of tobacco use and with indeterminate pulmonary nodules. Previously published lung cancer signatures were concordantly enriched among genes associated with lung cancer in the bronchial brushings and biopsies; however, only the results in the bronchial brushings were statistically significant. We found that biopsy samples could be classified into previously described lung squamous premalignant lesion molecular subtypes. There was a significant difference in smoking status among the subtypes, similar to prior characterization of the subtypes. There was no significant enrichment based on cancer diagnosis among the subtypes. We found enrichment for cell type-specific molecular signatures for stromal and immune cells in the biopsies compared to the bronchial brushings. While a cancer signature able to discriminate between patients with benign and cancerous lesions was challenging to derive in the biopsies, our results suggest that pathways related to cell metabolism, oxidative stress, and cell proliferation are upregulated in the biopsy samples from patients with cancer. Next, we investigated gene expression changes in lung adenocarcinoma premalignant lesions using lung resection cases with normal, premalignant, and tumor histology. RNA and DNA were isolated from laser capture microdissected tissue (representing a specific histology) and underwent mRNA and DNA exome sequencing. Using multiple gene expression datasets of lung adenocarcinoma premalignant lesions, we derived a set of recurrent gene co-expression modules. Using these modules, we identified four LUAD PML archetypes. In archetype analysis, samples closest to each vertex typically represent unique biological features. Analyzing how the expression of published gene signatures varies in samples as a function of distance from the archetypes suggests the archetypes differ with respect to the immune environment, cell signaling, and proliferation. Based on these enrichment patterns, the archetypes were named: normal-like, inflammation, cell adhesion, and proliferation. Samples closer to the inflammation and proliferation archetypes were associated with unique driver mutations, and samples closer to the proliferation archetype had increased features relating to genome instability. To more fully characterize the archetypes, we projected them into independent lung adenocarcinoma tumor datasets. Across multiple studies, tumors closest to the proliferation archetype were associated with decreased disease-free survival and with the presence of aggressive disease features. Archetype analysis allowed for identification of distinct features among lung adenocarcinoma premalignant lesions, and helped characterize them based on their relationship to aggressive disease features. In summary, I investigated gene expression changes in the airway to improve our understanding of lung cancer pathogenesis. Past research demonstrated that squamous premalignant lesions in the airway are a marker of risk of any type of lung cancer. To better understand these findings, we analyzed the relationship between cancer-associated signatures and premalignant lesion-associated signatures of airway biopsies. Past studies of lung adenocarcinoma demonstrated transcriptional differences between tumors and premalignant lesions. Our archetyping approach uniquely characterizes premalignant lesion-specific features that relate to pathway alterations and prognosis. Characterizing these premalignant lesion features may improve our understanding of divergent mechanisms of carcinogenesis and enable identification of aggressive lesions capable of developing into invasive cancer.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Bioinformatics
Grantor
Boston University
Year dc:date.issued
2027

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Anderson, Kelley
Advisors dc:contributor.advisor
  • Beane, Jennifer
  • Lenburg, Marc
ORCID dc:identifier.orcid

Subjects

dc:subject × 2

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52081

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Anderson, Kelley. Molecular subtypes of airway field gene expression alterations are associated with lung cancer phenotypes. doctoral thesis, Boston University, 2027. https://hdl.handle.net/2144/52081